In this study, we demonstrate for the first time that long-term fenofibrate intervention enhances liver steatosis in ob/ob mice, which is consistent with the findings in ob/ob and LDLR-double deficient mice (21). The gene discussed is LDLR; the disease is fatty liver disease.